Citation Impact
Citing Papers
Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation
2014
Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography
2011
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Impact of intravascular ultrasound in understanding transplant coronary artery disease
1999
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Acute kidney injury
2012 Standout
Comparison of Self-Report, Hospital Discharge Codes, and Adjudication of Cardiovascular Events in the Women's Health Initiative
2004
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
1998
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
2009
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
The β-Thalassemias
1999 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
National estimates of severe sepsis in United States emergency departments
2007
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction
1990
The development of positive inotropic agents for chronic heart failure: How have we gone astray?
1993
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Effect of Selective Cyclooxygenase 2 Inhibitors and Naproxen on Short-term Risk of Acute Myocardial Infarction in the Elderly
2003
Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart
1992
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis
1990
Prevention of Contrast-Induced AKI
2013
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
1992
Cardiovascular Effects of Continuous Positive Airway Pressure in Patients with Heart Failure and Obstructive Sleep Apnea
2003
Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat
1987
A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart Failure
1989
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
2010
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure
1989
Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.
1993
Atherosclerosis — An Inflammatory Disease
1999 Standout
Acetylcysteine in the Prevention of Contrast-Induced Nephropathy
2006
The effects of rate and irregularity on sympathetic nerve activity in human subjects
2006
Idarucizumab for Dabigatran Reversal
2015 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Effects of a Stimulant-Free Dietary Supplement on Body Weight and Fat Loss in Obese Adults: A Six-Week Exploratory Study
2003
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy
2002
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Inhibition of Spontaneous β2-Adrenergic Activation Rescues β1-Adrenergic Contractile Response in Cardiomyocytes Overexpressing β2-Adrenoceptor
2000 StandoutNobel
Management of Hypertensive Urgencies and Emergencies
1995
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Converting Enzyme Inhibition Specifically Prevents the Development and Induces Regression of Cardiac Hypertrophy in Rats
1989
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction
1990
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Chronic Heart Failure in the United States
1998
Survival of patients with severe congestive heart failure treated with oral milrinone
1986
Sodium Bicarbonate Improves Long-Term Clinical Outcomes Compared With Sodium Chloride in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
2008
Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.
1990
Pharmacological Approaches for the Treatment of Obesity
2002
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 Standout
Sleep Apnea and Heart Failure
2003
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.
1987
An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
1994
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
1997 Standout
Effects of milrinone on left ventricular remodeling after acute myocardial infarction.
1991
Fine-Particulate Air Pollution and Life Expectancy in the United States
2009 Standout
A Randomized Trial of Protocol-Based Care for Early Septic Shock
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cytokine Modulation of LDL Oxidation by Activated Human Monocytes
1997
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 Standout
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
2005 Standout
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
1994
Care and Outcomes of Patients Newly Hospitalized for Heart Failure in the Community Treated by Cardiologists Compared With Other Specialists
2003
Works of Paul Daly being referenced
Coronary sinus sampling of cytokines after heart transplantation: Evidence for macrophage activation and interleukin-4 production within the graft
1993
Combined Liver and Heart Transplantation for End-Stage Iron-Induced Organ Failure in an Adult with Homozygous Beta-Thalassemia
1994
N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up
2004
A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario
2002
The use of quantile regression in health care research: a case study examining gender differences in the timeliness of thrombolytic therapy
2004
Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries
1995
Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction
1989
Emergency department crowding and thrombolysis delays in acute myocardial infarction
2004
Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: Rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure
1987
Myocardial catecholamines and the pathophysiology of heart failure.
1990
Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure
1985
Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
1986
Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
1993
Acute effects of captopril on the coronary circulation of patients with hypertension and angina
1984
Milrinone in congestive heart failure: Acute and chronic hemodynamic and clinical evaluation
1985
Ephedrine, caffeine and aspirin promote weight loss in obese subjects.
1990
R013-6438, a new inotrope-vasodilator: Systemic and coronary hemodynamic effects in congestive heart failure
1985
Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect.
1985